Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7001
Deluxe
DLX
$1.1B
| $993K | ﹤0.01% |
43,963
-129,950
| -75% | -$2.79M |
|
|
ARTV
7002
Artiva Biotherapeutics
ARTV
$571M
| $992K | ﹤0.01% |
103,635
| – | – |
|
|
STKL
7003
DELISTED
SunOpta
STKL
| $991K | ﹤0.01% |
+128,678
| New | +$910K |
|
7004
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.8B
| $991K | ﹤0.01% |
3,904
+1,366
| +54% | +$352K |
|
7005
PUT
BlackLine
BL
$1.86B
| $990K | ﹤0.01% |
16,300
-198,000
| -92% | -$11.8M |
|
7006
CALL
ONE Gas
OGS
$5.12B
| $990K | ﹤0.01% |
14,300
-5,500
| -28% | -$401K |
|
7007
PUT
CG Oncology
CGON
$7.04B
| $989K | ﹤0.01% |
34,500
+14,300
| +71% | +$489K |
|
7008
Inogen
INGN
$150M
| $989K | ﹤0.01% |
107,829
+29,595
| +38% | +$277K |
|
7009
Alphatec Holdings
ATEC
$1.5B
| $988K | ﹤0.01% |
107,669
-64,873
| -38% | -$518K |
|
7010
PUT
SFL Corp
SFL
$1.68B
| $988K | ﹤0.01% |
96,700
-57,800
| -37% | -$617K |
|
|
SF
7011
PUT
Stifel
SF
$12.7B
| $987K | ﹤0.01% |
13,950
-5,100
| -27% | -$364K |
|
7012
CALL
Surgery Partners
SGRY
$1.84B
| $987K | ﹤0.01% |
46,600
+31,800
| +215% | +$834K |
|
7013
CALL
Agilon Health
AGL
$1.58B
| $986K | ﹤0.01% |
20,756
-64
| -0.3% | -$3.87K |
|
7014
Southern California Bancorp
BCAL
$685M
| $986K | ﹤0.01% |
+59,601
| New | +$959K |
|
7015
Kopin
KOPN
$924M
| $985K | ﹤0.01% |
+724,478
| New | +$695K |
|
7016
PUT
Par Pacific Holdings
PARR
$3.99B
| $985K | ﹤0.01% |
60,100
+30,400
| +102% | +$513K |
|
7017
Direxion Daily GOOGL Bull 2X ETF
GGLL
$944M
| $985K | ﹤0.01% |
21,531
-851
| -4% | -$34.6K |
|
7018
First Trust Multi-Strategy Alternative ETF
LALT
$324M
| $984K | ﹤0.01% |
46,866
+18,393
| +65% | +$388K |
|
|
HFSI
7019
Hartford Strategic Income ETF
HFSI
$1.09B
| $984K | ﹤0.01% |
28,685
-24,140
| -46% | -$844K |
|
7020
PUT
SIGA Technologies
SIGA
$213M
| $983K | ﹤0.01% |
163,600
-500
| -0.3% | -$3.34K |
|
|
CRON
7021
Cronos Group
CRON
$1.2B
| $983K | ﹤0.01% |
486,667
-25,085
| -5% | -$52.3K |
|
7022
CALL
Ocular Therapeutix
OCUL
$2.52B
| $983K | ﹤0.01% |
115,100
+76,000
| +194% | +$741K |
|
7023
PUT
Reinsurance Group of America
RGA
$15.7B
| $983K | ﹤0.01% |
4,600
-1,400
| -23% | -$305K |
|
|
DXUV
7024
Dimensional US Vector Equity ETF
DXUV
$577M
| $982K | ﹤0.01% |
+18,588
| New | +$1M |
|
|
SUPV
7025
PUT
Grupo Supervielle
SUPV
$670M
| $982K | ﹤0.01% |
65,000
-5,800
| -8% | -$61.9K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.